Publications by Center Staff

2001

Tanzi RE and Bertram L (2001). New frontiers in alzheimer’s disease genetics. Neuron; 32: 181-184.

2001

Bertram L and Tanzi RE (2001). Of replications and refutations:  the status of alzheimer’s disease genetic research. Current Neurology and Neuroscience Reports; 1: 442-450.

2001

Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H and Drachman DA (2001). Postmenopausal estrogen replacement therapy and the risk of alzheimer’s disease. Arch Neurol; 58: 435-440.

2001

Drachman DA (2001). Practice parameters:  diagnosis, treatment, and early detection of dementia. Journal Watch Neurology; 3: 66.

2001

Narayanan K, Collins JJ, Hamner J, Mukai S and  Lipsitz LA (2001).  Predicting the cerebral blood flow response to orthostatic stress:  effects of age on the pressure-flow impulse response function. Am J of Phy; 821: R716-R722.

2001

Swearer J, O’Donnell BF, Parker M, Kane KJ and Drachman DA (2001). Psychological features in persons at risk for familial alzheimer’s disease. Am J Alz Dis and Dementias; 16: 157-162.

2001

Cho HS, Hyman BT, Greenberg SM and Rebeck GW (2001). Quantitation of apoe domains in alzheimer disease brain suggests a role for apoE in a-beta aggregation. J Neuropath and Exp Neurol; 60: 342-349.

2001

Adamec E, Chang HT, Stopa EG, Hedreen JC and Vonsattel JP (2001). Tau protein expression in frontotemporal dementias. Neurosci Letters; 315: 21-24.

2001

Kimberly WT, Zheng JB, Guenette S and Selkoe DJ (2001). The intracellular domain of the ß-amyloid precursor protein is stabilized by fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem; 276: 40288-40292.

2001

Hock C, Maddalena A, Heuser I, Naber D, Oertel W, von der Kammer H, Wienrich M, Raschig A, Deng M, Growdon JH and Nitsch, RM (2001). Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with alzheimer’s disease. Annals NY Acad Sci; 920: 285-291.